Chipscreen Biosciences Announced NMPA Approval of IND for CS43158, an AML Candidate Discovered via the AI-enabled Chemical Genomics Platform

Posted on by sHq_LoGiNz

SHENZHEN, China–(BUSINESS WIRE)– #AI–Chipscreen Biosciences announced that China NMPA has approved the IND application for CS43158 tablets, a new molecular entity for the treatment of AML

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.